News

Video

Frontline Therapy for Advanced Renal Cell Carcinoma: Patient Scenario Discussion

Author(s):

Ulka Vaishampayan, MD,Alan Tan, MD

Renowned oncologists discuss the case of a 75-year-old man with advanced renal cell carcinoma, providing insights into evaluation and frontline therapy choices.

Related Videos
Alan Tan, MD, Vanderbilt-Ingram Cancer Center
5 KOLs are featured in this series.
5 KOLs are featured in this series.
Chad Tang, MD
5 KOLs are featured in this series.
Martin H. Voss, MD
Related Content
Douglas W. Sborov, MD, MS
October 28th 2024

CAR T-Cell Therapies Extend Treatment-Free Intervals in Multiple Myeloma With Regular Toxicity Monitoring

Guillermo Garcia-Manero, MD, professor, chief, section of Myelodysplastic Syndromes, deputy chair, Translational Research, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
August 19th 2024

Garcia-Manero on MDS Treatment Updates With Luspatercept and Beyond

Michael Wang, MD
October 22nd 2024

Acalabrutinib Plus Venetoclax/Rituximab Yields 100% ORR in Treatment-Naive Mantle Cell Lymphoma

Shannon N. Westin, MD, MPH, FACOG, professor, clinical medical director, Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, The University of Texas MD Anderson Cancer Center
August 15th 2024

FDA Approval Insights: Durvalumab/Chemotherapy in dMMR Advanced Endometrial Cancer

Neeraj Agarwal, MD, FASCO
October 17th 2024

Cabozantinib Plus Atezolizumab Fails to Improve OS Over Subsequent Novel Hormonal Therapy in mCRPC

Chad Tang, MD
October 15th 2024

Prospective Trials Could Refine Potential Roles for Radiation in Advanced RCC